Atrial Fibrillation NETwork

Recent papers from Atrial Fibrillation NETwork

1. Atrial Fibrillation Burden as an Outcome in Clinical TrialsNEJM Evidence · 2026
2. Repeat Ablation for Persistent Atrial Fibrillation: CFA/DOA-Guided Substrate Ablation Versus Re-PVI Alone in the Prematurely Terminated Randomized AF-CAM TrialJournal of Clinical Medicine · 2026
3. Association of the EHRA/HRS/APHRS/LHRS definition of atrial cardiomyopathy with incident atrial fibrillation, heart failure, and strokeEP Europace · 2026
4. Early rhythm control in patients with atrial fibrillation and cancer: A subgroup analysis of the EAST-AFNET 4 trialEP Europace · 2026
5. The Role of Psychological Stress in Atrial Fibrillation: Completing the Translational Circle from Molecular Mechanisms to Citizen ScienceEuropean Journal of Preventive Cardiology · 2026
6. Pacemaker-implantation and atrioventricular-node ablation vs pulmonary vein isolation for elderly patients with persistent atrial fibrillation: the ABLATE versus PACE trialEuropean Heart Journal · 2026
7. Catheter ablation for atrial fibrillation in very young adults — multicentric data from the AF-YOUNG registryHeart Rhythm · 2026
8. Catheter ablation for symptomatic atrial fibrillation (PVI-SHAM-AF): a randomised, double-blind, sham-controlled, multicentre trialThe Lancet · 2026
9. Anticoagulation for Atrial Fibrillation with a Single Risk Factor for StrokeNew England Journal of Medicine · 2026
10. Atrial Fibrillation and Dementia: A Report From the AF-SCREEN International CollaborationCirculation · 2022
11. 2026 AHA/ACC Clinical Performance and Quality Measures for Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Performance MeasuresCirculation Population Health and Outcomes · 2026
12. Interactions of blood biomolecules with early rhythm control in atrial fibrillation patients: Exploratory analysis of the EAST-AFNET 4 Biomolecule StudyEP Europace · 2026
13. AF-B-STEP: a global collaboration to reduce the burden of atrial fibrillation and advance its quantification and treatmentEuropean Heart Journal · 2026
14. Edoxaban for atrial fibrillation in patients with atherosclerotic disease in daily clinical practiceJournal of Thrombosis and Thrombolysis · 2026
15. Effectiveness and Safety of Early Rhythm Control in Patients With Atrial Fibrillation and Chronic Kidney DiseaseJournal of the American College of Cardiology · 2026
16. Quantifying atrial fibrillation to improve risk estimation: the growing role of AF burden and a new density kid on the blockEuropean Heart Journal · 2026
17. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trialEuropean Heart Journal · 2022
18. Rare coding variant architecture and gene discovery from 130,000 sequenced cases of atrial fibrillation2026
19. Kidney disease increases the risk of cardiovascular events in patients with device-detected atrial fibrillation: NOAH-AFNET 6EP Europace · 2026
20. The CIRCULAR model: advancing public health through citizen science initiated clinical and mechanistic research in atrial fibrillationFrontiers in Public Health · 2026